Market News AIOpen the app

Pomdoctor is at risk of being removed from Nasdaq.

TroubleRead the original at Benzinga
Bad for POM

Pomdoctor's sales grew, but its loss jumped as operating costs rose. A possible trading suspension after its shares stayed below Nasdaq's $1 rule outweighs the sales gain.

POM · Pomdoctor Ltd.

AI read · Bad for POM

The AI's read

An appeal may let Pomdoctor keep trading for now, and the article says it probably filed one. Still, its shares remained below $1 after a reverse split, and its loss grew sharply as operating costs jumped. Sales growth is a real positive, but it does not outweigh the suspension threat and widening loss.

Get alerts for POM

Follow Pomdoctor Ltd. (POM) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for POM
Free on the App Store and Google Play, or on the web.